United KingdomNew data from the Medicines and Healthcare Products Regulatory Agency (MHRA) reveals over 200 suspected deaths linked to weight loss injections such as Wegovy and Mounjaro, alongside more than 150,000 adverse reactions reported. The MHRA's Yellow Card Scheme indicates that tirzepatide (Mounjaro) has seen 120 suspected deaths and 106,189 adverse reactions, while semaglutide (Wegovy/Ozempic) has 59 suspected deaths and 48,089 reactions. The agency clarifies that these reports reflect suspicions rather than confirmed causation, emphasizing ongoing safety reviews and the importance of regulatory oversight. Health Secretary Yvette Cooper reiterated the robust regulatory framework ensuring monitoring of adverse effects.
Bias read (Center): The article presents factual data from the MHRA without overtly criticizing or praising the pharmaceutical companies or government regulators. It emphasizes the regulatory process and the balance between benefits and risks, avoiding strong ideological framing. While the issue of drug safety is undem
